Di Maio, Roberto <br/><br/>
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats.  [electronic resource] 

 -  Neurobiology of disease  Jan 2015 
 - 356-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-953X 
<br/><br/><label>Standard No.: </label>10.1016/j.nbd.2014.10.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzoxazines--pharmacology<br/>Cannabinoid Receptor Agonists--pharmacology<br/>Chronic Disease--prevention & control<br/>Disease Models, Animal<br/>Epilepsy--prevention & control<br/>Hippocampus--drug effects<br/>Male<br/>Morpholines--pharmacology<br/>Naphthalenes--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Status Epilepticus--chemically induced